Events & Presentations

Featured Event

Featured Presentation

Upcoming Events

Date Event
April 12, 2018 02:10 AM EDT
Boston, MA United States

Speaker(s):

  • Dr. Tony Ting, Vice President of Regenerative Medicine and Head of Cardiopulmonary Programs
May 10, 2018 04:30 PM EDT

Athersys, Inc. (Nasdaq:ATHX) will release its first quarter 2018 financial results at approximately 4:00 PM Eastern Time on Thursday, May 10, 2018, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Gil Van Bokkelen, Chairman and Chief Executive Officer, and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call.

Date: May 10, 2018
Time: 4:30 p.m. (Eastern Time)
Telephone access: US and Canada - (800) 273-1254
Telephone access: International - (973) 638-3440
Access code: 1189915

June 18, 2018 11:00 AM EDT

We invite all of our shareholders to attend our annual meeting, scheduled for Monday June 18th at the Westin Cleveland Hotel, located at 777 St. Clair Ave NE in Cleveland. A continental breakfast will be served at 11 AM and the meeting will follow at 11:30 AM.

June 19, 2018 01:50 PM AEST
Melbourne, Australia
Walter and Eliza Hall Institute of Medical Research

Speaker(s):

  • Sarah Busch, PhD, Associate Director of Regenerative Medicine - Athersys, Inc.

Dr. Sarah Busch will present at the Pre-Meeting Education Session II: Cellular Therapy in the Nervous System.

Pre-Meeting Education Schedule

August 7, 2018 04:30 PM EDT

Athersys, Inc. (NASDAQ:ATHX) will release its second quarter 2018 financial results at approximately 4:00 PM Eastern Time on Tuesday, August 7th, 2018, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Laura Campbell, Senior Vice President of Finance and William (B.J.) Lehmann, President and Chief Operating Officer, will host the call as follows:

Date August 7, 2018
Time 4:30 p.m. (Eastern Time)
Telephone access: US and Canada (800) 273-1254
Telephone access: International (973) 638-3440
Access code 5144048
October 3, 2018 05:30 PM PDT
La Jolla, CA
Ballroom 1 at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037

Speaker(s):

  • Gil Van Bokkelen Ph.D., Chairman and CEO

Dr. Van Bokkelen will provide a brief overview of the Athersys’ clinical pipeline, focusing on the ongoing Phase 3 trial of MultiStem® cell therapy for the treatment of ischemic stroke that has received Fast Track and RMAT designation from the U.S. Food and Drug Administration, positive scientific advice from the European Medicines Agency, and is being conducted under a Special Protocol Assessment (SPA).

In addition, Dr. Van Bokkelen has been invited to speak at two conference workshops, where he will describe the Company’s progress working in collaboration with Healios K.K. under the innovative regenerative medicine regulatory framework implemented in Japan as part of the “Doing Business in Japan” workshop. During the “Readiness Strategies for Cell Therapy – Commercial Manufacturing” workshop, Dr. Van Bokkelen will discuss commercial manufacturing approaches and technologies for cellular therapies.

Event: Doing Business in Japan Workshop: Development of an “Off the Shelf” Cell Therapy for Ischemic Stroke and Other Indications Under the Regenerative Medicine Regulatory Framework in Japan
Date: October 3, 2018
Time: 7:50 – 8:05 am Pacific Time
Location: Magnolia Room at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037

Event: Athersys Corporate Overview
Date: October 3, 2018
Time: 5:30 – 5:45 pm Pacific Time
Location: Ballroom 1 at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 92037

Event: Readiness Strategies for Cell Therapy – Commercial Manufacturing Workshop, Section 3 Technology
Date: October 4, 2018
Time: 8:10 – 8:35 am Pacific Time
Location: Learning Theater at the Estancia La Jolla Hotel & Spa, 9700 North Torrey Pines Road, La Jolla, CA 9203

November 6, 2018 04:30 PM EST

Telephone access: US and Canada (800) 273-1254
Telephone access: International (973) 638-3440
Access code 7396506

January 7, 2019
San Francisco, CA

Athersys will be attending the JP Morgan Healthcare conference, where companies gather to share exciting advances that are driving medical #innovation to help transform clinical care for patients.

April 9, 2019 10:00 AM ET
Westin Grand Central Hotel, New York City

Speaker(s):

  • Gil Van Bokkelen, Chairman and CEO
May 9, 2019
Boston, MA

Speaker(s):

  • Greg Liposky, MBA, Senior Vice President of Commercial Manufacturing at Athersys

Greg Liposky, MBA, Senior Vice President of Commercial Manufacturing at Athersys will be chairing the day 2 session and giving a presentation at 10 AM ET titled “Establishing Long-Term Strategic Plans for Commercial Manufacturing of Allogeneic Cell Therapies”. The presentation will include an overview of Athersys, MultiStem- a novel therapy for the treatment of ischemic stroke, and discuss the factors to consider in planning for product commercialization, such as process scalability, process reliability and process reproducibility.

May 14, 2019 08:00 AM

Thank you to everyone that attended the event. To view a highlight video of the event, please fill out this form. Your name and a valid email address is required for viewing.

May 20, 2019
Dallas, Texas

Speaker(s):

  • Dr. Geoff Bellingan, Medical Director at University College London Hospitals

Dr. Bellingan will present the data from the Athersys ARDS trial. His presentation is titled “Primary Analysis of a Phase 1/2 Study to Assess MultiStem® Cell Therapy, a Regenerative Advanced Therapy Medicinal Product (ATMP), in Acute Respiratory Distress Syndrome (MUST-ARDS)” Monday May 20, 2019 9:15 AM - 11:15 AM

June 12, 2019 08:30 AM EDT
The Ritz-Carlton – The Hideaway Room, 1515 W. 3rd Street, Cleveland, Ohio 44113

Registration opens at 7:30 AM EDT

Advanced registration is required, please register here: https://www.athersys.com/investors/resources/annual-information/default.aspx

August 7, 2019 04:30 PM EDT

Athersys, Inc. (Nasdaq: ATHX) will release its second quarter 2019 financial results at approximately 4:00 PM Eastern Time on Wednesday, August 7, 2019, and will host a conference call shortly thereafter at 4:30 PM Eastern Time to review the results. Members of the management team will host the call as follows:

Date - August 7, 2019
Time - 4:30 p.m. (Eastern Time)
Telephone access: US and Canada (877) 396-3286
Telephone access: International (647) 689-5528
Encore Passcode (needed for the replay only) 5087881

We encourage shareholders to listen using the webcast link and to use the phone line if you intend to ask a question. A replay will be available on the webcast at www.athersys.com under the investors section approximately two hours after the call has ended. Shareholders may also call in for on-demand listening shortly after the completion of the call until 11:59 PM Eastern Time on August 14, 2019 by dialing (800) 585-8367 or (416) 621-4642 and entering Encore passcode 5087881.

September 13, 2019 08:45 AM CT
Monona Terrace Community & Convention Center, 1 John Nolen Drive, Madison, Wisconsin 53703

Speaker(s):

  • Dr. Gil Van Bokkelen, Chairman and CEO

Plenary 1: Mesenchymal and Progenitor Stem Cells: Results from the Clinic and the Future of Living Drugs

Mesenchymal and Progenitor Stem Cells have begun to show clear evidence of efficacy outstanding safety profile in early clinical trials. This session aims to bring together some of those trials that are in the most advanced stages of testing. The presenters will each highlight the results from their efforts to with an emphasis on the lessons learned from these trials and their approach toward answering critical questions for the future of these technologies including purity, potency and logistics considerations.

For more information about the conference, please visit ISCT North America 2019. 

 

October 3, 2019 05:45 PM PT
Park Hyatt Aviara Resort, 7100 Aviara Resort Dr., Carlsbad, CA 92011

Speaker(s):

  • Dr. Gil Van Bokkelen, Chairman & CEO

BlueRock Therapeutics Ballroom

For more information, please click here.

October 29, 2019 02:25 PM ET
Jupiter, Florida

Speaker(s):

  • Gil Van Bokkelen, Chairman and Chief Executive Officer

Track 2, Preserve Ballroom B

For more information, click here


 

November 13, 2019 12:15 PM IST
Glenlo Abbey Hotel, National University of Galway, University Road, Galway,Ireland H91TK33

Speaker(s):

  • Bart Vaes, Associate Director, Site Leader, ReGenesys

Clinical Development of MultiStem(R) Therapies

For more information: please click here.

December 11, 2019 08:00 AM PT
San Diego, CA

Speaker(s):

  • Dr. Robert (Willie) Mays, Ph.D., Vice President of Regenerative Medicine and Head of Neuroscience Programs

Wednesday, December 11, 2019

Cellular Therapies and Novel Blood Products in Trauma and Critical Care – The Future of Transfusion Medicine

Session 2: Challenges in Product Development, Cell Production and Processing

Cell Production Panel

4:25 – 5:25 p.m.

 

Friday, December 13, 2019

Cellular Therapies in Trauma and Critical Care Medicine

Session 1: Cellular Therapies in Critical Care Medicine

 “Multipotent Adult Progenitor Cells in ARDS”

9:50 – 10:10 a.m.

Events Archive